The inhibition of human factor Xa by plasminogen activator inhibitor type 1 in the presence of calcium ion, and its enhancement by heparin and vitronectin

被引:15
作者
Urano, T
Ihara, H
Takada, Y
Nagai, N
Takada, A
机构
[1] HAMAMATSU UNIV SCH MED, DEPT PHYSIOL, HAMAMATSU, SHIZUOKA 43131, JAPAN
[2] HAMAMATSU UNIV SCH MED, DEPT PATHOPHYSIOL, HAMAMATSU, SHIZUOKA 43131, JAPAN
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY | 1996年 / 1298卷 / 02期
关键词
factor Xa; plasminogen activator inhibitor type 1; calcium ion; heparin; vitronectin;
D O I
10.1016/S0167-4838(96)00131-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasminogen activator inhibitor type 1 (PAI-1), a member of serine proteinase inhibitor superfamily, is known to inhibit thrombin in the presence of either heparin or vitronectin. We analyzed possible inhibitory activity of PAI-1 on human factor Xa, PAI-1 inhibited factor Xa in the presence of calcium ion (Ca2+), whereas no inhibition was observed in the absence of Ca2+, Half maximal enhancement by Ca2+ was obtained at 0.8 mM. An equimolar complex formation between factor Xa and PAI-1 in the presence of Ca2+ was observed by SDS polyacrylamide gel electrophoresis. Both unfractionated heparin and vitronectin enhanced the inhibition only in the presence of Ca2+. Apparent second-order rate constant (k(i)) for the inhibition of factor Xa by PAI-1 at 5 mM Ca2+ was 1.6 x 10(4) M(-1) s(-1), and was enhanced 3-fold by 2 u/ml of heparin (4.6 x 10(4) M(-1) s(-1)) and 10-fold by 100 nM vitronectin (1.6 x 10(5) M(-1) s(-1)), respectively. The interaction between Ca2+-bound factor Xa and PAI-1 could be important from the view of PAI-1 neutralization and enhancement of fibrinolysis.
引用
收藏
页码:199 / 208
页数:10
相关论文
共 47 条
[1]  
Binder B R, 1990, Blood Coagul Fibrinolysis, V1, P717
[2]   GLYCOSAMINOGLYCANS AND THE REGULATION OF BLOOD-COAGULATION [J].
BOURIN, MC ;
LINDAHL, U .
BIOCHEMICAL JOURNAL, 1993, 289 :313-330
[3]   PHYSIOLOGICAL CONSEQUENCES OF LOSS OF PLASMINOGEN-ACTIVATOR GENE-FUNCTION IN MICE [J].
CARMELIET, P ;
SCHOONJANS, L ;
KIECKENS, L ;
REAM, B ;
DEGEN, J ;
BRONSON, R ;
DEVOS, R ;
VANDENOORD, JJ ;
COLLEN, D ;
MULLIGAN, RC .
NATURE, 1994, 368 (6470) :419-424
[4]  
Carrell R.W, 1986, PROTEINASE INHIBITOR, P403
[5]   MOBILE REACTIVE CENTER OF SERPINS AND THE CONTROL OF THROMBOSIS [J].
CARRELL, RW ;
EVANS, DL ;
STEIN, PE .
NATURE, 1991, 353 (6344) :576-578
[6]   KINETICS OF THE INHIBITION OF PLASMINOGEN ACTIVATORS BY THE PLASMINOGEN-ACTIVATOR INHIBITOR - EVIDENCE FOR 2ND SITE INTERACTIONS [J].
CHMIELEWSKA, J ;
RANBY, M ;
WIMAN, B .
BIOCHEMICAL JOURNAL, 1988, 251 (02) :327-332
[7]  
COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77
[8]  
DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454
[9]   ANGIOTENSINOGEN IS RELATED TO THE ANTITRYPSIN-ANTITHROMBIN-OVALBUMIN FAMILY [J].
DOOLITTLE, RF .
SCIENCE, 1983, 222 (4622) :417-419
[10]  
EDELBERG JM, 1991, J BIOL CHEM, V266, P7488